The Drugs Controller General of India (DCGI) on Friday will review applications filed by Bharat
Issuing a statement, Bharat Biotech said the goals of developing a global vaccine against COVID-19
The Serum Institute had earlier sought the approval of the SEC to administer the third dose of its
Giving further details, Poonawala said the focus of the Central government should be on giving both
The Serum Institute will commence its Covid vaccine export under the COVAX programme from November
It must be noted that Covishield and Covaxin, which received emergency use listing (EUL) from the
The SII has also submitted interim phase 2/3 clinical study report on Indian adults, the interim
Speedy permissions granted by the government authorities made the development of the coronavirus
The approval comes at a time when Covishield has been omitted by the European Medicines Agency
The Novavax vaccine uses purified pieces of coronavirus rather than mRNA.
This development comes days after Centre announced fresh Covid vaccine procurement guidelines
Serum Institute has already informed the government that it will be able to manufacture and supply
Indian Businessman, Philanthropist, vaccine maker popularly known as India's 'Vaccine Prince' is
The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of
Tamil Nadu Health Secretary has said the state government has ordered for 1.5 crore vaccines.
Vaccine maker Serum Institute of India (SII) today defended pricing Covishield vaccine at 1.5 times
Covovax is a protein-based COVID-19 vaccine developed by American company Novavax, headquartered in
Measures about 25,000 square feet (2,322 square meters), the mansion is one of the largest
Ajit Pawar said the fire was caused due to short circuit and there was no foul play involved.